Neuromuscular Block and Blocking Agents in 2018.
作者信息
Unterbuchner Christoph
机构信息
Department of Anesthesiology, University Medical Centre Regensburg Franz-Josef-Strauss-Allee 11 93053 Regensburg, Germany.
出版信息
Turk J Anaesthesiol Reanim. 2018 Apr;46(2):75-80. doi: 10.5152/TJAR.2018.200318. Epub 2018 Apr 1.
Abstract
摘要
相似文献
1
Neuromuscular Block and Blocking Agents in 2018.2018年的神经肌肉阻滞与阻滞剂
Turk J Anaesthesiol Reanim. 2018 Apr;46(2):75-80. doi: 10.5152/TJAR.2018.200318. Epub 2018 Apr 1.
2
Interactions of neuromuscular blocking drugs.神经肌肉阻滞药物的相互作用。
Acta Anaesthesiol Belg. 2001;52(4):357-63.
3
Interactions between ORG9426 and other non-depolarizing neuromuscular blocking agents in rats in vivo.
J Anesth. 1992 Jul;6(3):277-83. doi: 10.1007/s0054020060277.
4
Monitoring and reversal of neuromuscular block.
Am J Health Syst Pharm. 1999 Jun 1;56(11 Suppl 1):S10-3. doi: 10.1093/ajhp/56.S10.
5
The new neuromuscular blocking agents: do they offer any advantages?
Br J Anaesth. 2001 Dec;87(6):912-25. doi: 10.1093/bja/87.6.912.
6
Development and potential clinical impairment of ultra-short-acting neuromuscular blocking agents.超短效神经肌肉阻滞剂的开发和潜在临床损害。
Br J Anaesth. 2011 Dec;107 Suppl 1:i60-71. doi: 10.1093/bja/aer341.
7
Under-dosing and over-dosing of neuromuscular blocking drugs and reversal agents: beware of the risks.
Br J Anaesth. 2024 Mar;132(3):461-465. doi: 10.1016/j.bja.2023.12.001. Epub 2023 Dec 21.
8
Paradoxical antagonism of neuromuscular block by vecuronium metabolites.
Acta Med Okayama. 1985 Dec;39(6):471-80. doi: 10.18926/AMO/31502.
9
Selecting neuromuscular-blocking drugs for elderly patients.为老年患者选择神经肌肉阻滞剂
Drugs Aging. 2003;20(2):125-40. doi: 10.2165/00002512-200320020-00004.
10
Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient.成人危重症患者持续神经肌肉阻滞的临床实践指南。
Crit Care Med. 2016 Nov;44(11):2079-2103. doi: 10.1097/CCM.0000000000002027.
引用本文的文献
1
Analysis of characteristics of patients whose sugammadex claims were denied by the Auto Insurance Claims Review Department of Korean Health Insurance Review & Assessment Service: a retrospective single-center review.韩国健康保险审查与评估服务机构自动保险理赔审查部拒绝舒更葡糖钠理赔申请的患者特征分析：一项回顾性单中心研究
Anesth Pain Med (Seoul). 2025 Apr;20(2):141-150. doi: 10.17085/apm.24095. Epub 2024 Nov 22.
2
Comparison of Effects of Sugammadex and Neostigmine on Postoperative Neuromuscular Blockade Recovery in Patients with Interstitial Lung Diseases Undergoing Transbronchial Cryobiopsy: A Randomized Trial.比较舒更葡糖钠和新斯的明对经支气管冷冻活检术的间质性肺疾病患者术后神经肌肉阻滞恢复的影响：一项随机试验。
Med Sci Monit. 2024 May 1;30:e942773. doi: 10.12659/MSM.942773.
3
Rate of residual neuromuscular block using single-dose rocuronium in general anesthesia for ENT surgery: a retrospective cohort study.全麻下单次使用罗库溴铵用于耳鼻喉科手术时的残余神经肌肉阻滞发生率：一项回顾性队列研究。
BMC Anesthesiol. 2023 Apr 1;23(1):107. doi: 10.1186/s12871-023-02027-x.
4
Predictive study of pharmacological reversal for residual neuromuscular blockade and postoperative pulmonary complications: a prospective, observational, cohort study.预测性研究：药物拮抗残余神经肌肉阻滞与术后肺部并发症的关系：一项前瞻性、观察性、队列研究。
Sci Rep. 2022 Sep 2;12(1):14955. doi: 10.1038/s41598-022-18917-y.
5
[Algorithm-based preventive strategies for avoidance of residual neuromuscular blocks].基于算法的预防策略以避免残余神经肌肉阻滞
Anaesthesist. 2019 Nov;68(11):744-754. doi: 10.1007/s00101-019-00677-6.
本文引用的文献
1
[Deep neuromuscular blockade : Benefits and risks].[深度神经肌肉阻滞：益处与风险]
Anaesthesist. 2018 Mar;67(3):165-176. doi: 10.1007/s00101-018-0425-6.
2
The comparative efficacy and safety of sugammadex and neostigmine in reversing neuromuscular blockade in adults. A Cochrane systematic review with meta-analysis and trial sequential analysis.舒更葡糖钠与新斯的明逆转成人神经肌肉阻滞作用的比较疗效和安全性。一项 Cochrane 系统评价，包含荟萃分析和试验序贯分析。
Anaesthesia. 2018 May;73(5):631-641. doi: 10.1111/anae.14160. Epub 2017 Dec 27.
3
Consensus Statement on Perioperative Use of Neuromuscular Monitoring.围术期使用神经肌肉监测专家共识
Anesth Analg. 2018 Jul;127(1):71-80. doi: 10.1213/ANE.0000000000002670.
4
Neostigmine-based reversal of intermediate acting neuromuscular blocking agents to prevent postoperative residual paralysis: A systematic review.新斯的明类药物逆转中效神经肌肉阻滞剂以预防术后残余性瘫痪：一项系统评价。
Eur J Anaesthesiol. 2018 Mar;35(3):184-192. doi: 10.1097/EJA.0000000000000741.
5
Reversal of residual neuromuscular block: complications associated with perioperative management of muscle relaxation.残余神经肌肉阻滞的逆转：与肌肉松弛围手术期管理相关的并发症。
Br J Anaesth. 2017 Dec 1;119(suppl_1):i53-i62. doi: 10.1093/bja/aex318.
6
Neostigmine Administration after Spontaneous Recovery to a Train-of-Four Ratio of 0.9 to 1.0: A Randomized Controlled Trial of the Effect on Neuromuscular and Clinical Recovery.自主恢复至四个成串刺激比值为0.9至1.0后给予新斯的明：对神经肌肉和临床恢复影响的随机对照试验
Anesthesiology. 2018 Jan;128(1):27-37. doi: 10.1097/ALN.0000000000001893.
7
Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.舒更葡糖钠与新斯的明在成人中逆转神经肌肉阻滞的疗效与安全性比较
Cochrane Database Syst Rev. 2017 Aug 14;8(8):CD012763. doi: 10.1002/14651858.CD012763.
8
Neuromuscular Monitoring in the Perioperative Period.围手术期神经肌肉监测。
Anesth Analg. 2018 Feb;126(2):464-468. doi: 10.1213/ANE.0000000000002387.
9
Development of an algorithm using clinical tests to avoid post-operative residual neuromuscular block.利用临床测试开发一种算法以避免术后残余神经肌肉阻滞。
BMC Anesthesiol. 2017 Aug 4;17(1):101. doi: 10.1186/s12871-017-0393-4.
10
Deep neuromuscular block to optimize surgical space conditions during laparoscopic surgery: a systematic review and meta-analysis.深肌松在腹腔镜手术中优化手术空间条件的效果：系统评价和荟萃分析。
Br J Anaesth. 2017 Jun 1;118(6):834-842. doi: 10.1093/bja/aex116.
Zotero 插件